Thus, this study revealed that simultaneous inhibition of downstream EGFR effectors and the glutathione antioxidant pathway could mimic Nrf2 ablation and limit pancreatic cancer growth. This evidence concerns the gene EGFR and familial pancreatic carcinoma.